• FirefoxInstall the new Firefox »
  •  Dow Down1.16% Nasdaq Down0.83%

    AVEO Pharmaceuticals, Inc. (AVEO)

    1.72 Up 0.30(21.13%) 12:49PM EST - Nasdaq Real Time Price
    Add to Portfolio
    HeadlinesGet Headlines for:
    [audio] [audio] AVEO Oncology Biomarker Analysis from Phase 2 Clinical Study of Tivozanib in Patients with Advanced Colorectal Cancer (recorded earlier today)

    No headlines available for AVEO prior to February 19, 2013.